-
-
-
-
-
-
-
Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million
-
-
-
-
-
-
-
Jeff Jonker Joins Ambys Medicines as President and CEO
-
-
-
-
-
-
-
Lightstone Ventures Adds Susan Molineaux as Scientific Advisor
-
1,179,088 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

